Control Measures for Communicable Diseases and Infestations | Midpage

Collections
Arizona Administrative Code

3

Control Measures for Communicable Diseases and Infestations

Department of Health Services - Communicable Diseases and Infestations

R9-6-301Definitions R9-6-302Local Health Agency Control Measures R9-6-303Isolation, Quarantine, Exclusion, and Other Control Measures R9-6-304Food Establishment Control Measures R9-6-305Control Measures for Multi-drug-resistant Organisms R9-6-306Amebiasis R9-6-307Anaplasmosis R9-6-308Anthrax R9-6-309Arboviral Infection R9-6-310Babesiosis R9-6-311Basidiobolomycosis R9-6-312Blastomycosis Infection R9-6-313Botulism R9-6-314Brucellosis R9-6-315Campylobacteriosis R9-6-316Candida auris R9-6-317Carbapenem-resistant Acinetobacter baumannii R9-6-318Carbapenem-resistant Enterobacterales R9-6-319Carbapenem-resistant Pseudomonas aeruginosa R9-6-320Chagas Infection and Related Disease (American Trypanosomiasis)R9-6-321Chancroid (Haemophilus ducreyi)R9-6-322Chikungunya R9-6-323Chlamydia trachomatis Infection R9-6-324Cholera R9-6-325Clostridioides difficile R9-6-326Coccidioidomycosis (Valley Fever)R9-6-327Colorado Tick Fever R9-6-328Conjunctivitis: Acute R9-6-329Creutzfeldt-Jakob Disease R9-6-330Cronobacter Infection in an Infant R9-6-331Cryptosporidiosis R9-6-332Cyclospora Infection R9-6-333Cysticercosis R9-6-334Dengue R9-6-335Diarrhea, Nausea, or Vomiting R9-6-336Diphtheria R9-6-337Ehrlichiosis R9-6-338Emerging or Exotic Disease R9-6-339Encephalitis, Viral or Parasitic R9-6-340Escherichia coli, Shiga Toxin-producing R9-6-341Giardiasis R9-6-342Glanders R9-6-343Gonorrhea R9-6-344Haemophilus influenzae: Invasive Disease R9-6-345Hansen’s Disease (Leprosy)R9-6-346Hantavirus Infection R9-6-347Hemolytic Uremic Syndrome R9-6-348Hepatitis A R9-6-349Hepatitis B and Hepatitis D R9-6-350Hepatitis C R9-6-351Hepatitis E R9-6-352HIV Infection and Related Disease R9-6-353Influenza-Associated Mortality in a Child R9-6-354Legionellosis (Legionnaires’ Disease)R9-6-355Leptospirosis R9-6-356Listeriosis R9-6-357Lyme Disease R9-6-358Lymphocytic Choriomeningitis R9-6-359Malaria R9-6-360Measles (Rubeola)R9-6-361Melioidosis R9-6-362Meningococcal Invasive Disease R9-6-363Methicillin-resistant Staphylococcus aureus (MRSA)R9-6-364Middle East Respiratory Syndrome (MERS)R9-6-365Mpox R9-6-366Mumps R9-6-367Mycoplasma genitalium Infection R9-6-368Norovirus R9-6-369Novel Coronavirus R9-6-370Novel Influenza Virus R9-6-371Pediculosis (Lice Infestation)R9-6-372Pertussis (Whooping Cough)R9-6-373Plague R9-6-374Poliomyelitis (Paralytic or Non-paralytic)R9-6-375Psittacosis (Ornithosis)R9-6-376Q Fever R9-6-377Rabies in a Human R9-6-378Relapsing Fever (Borreliosis)R9-6-379Respiratory Disease in a Health Care Institution or Correctional Facility R9-6-380Rubella (German Measles)R9-6-381Rubella Syndrome, Congenital R9-6-382Salmonellosis R9-6-383Severe Acute Respiratory Syndrome (SARS)R9-6-384Scabies R9-6-385Shigellosis R9-6-386Smallpox R9-6-387Spotted Fever Rickettsiosis (e.g., Rocky Mountain Spotted Fever)R9-6-388Streptococcal Group A Infection R9-6-389Streptococcal Group B Invasive Infection in an Infant Younger Than 90 Days of Age R9-6-390Streptococcus pneumoniae Invasive Infection R9-6-391Syphilis R9-6-392Taeniasis R9-6-393Tetanus R9-6-394Toxic Shock Syndrome R9-6-395Trichinosis R9-6-396Tuberculosis R9-6-397Tularemia R9-6-398Typhoid Fever R9-6-399Typhus Fever R9-6-3100Vaccinia-related Adverse Event R9-6-3101Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus R9-6-3102Varicella (Chickenpox)R9-6-3103Vibrio Infection R9-6-3104Viral Hemorrhagic Fever R9-6-3105West Nile Virus Infection R9-6-3106Yellow Fever R9-6-3107Yersiniosis (Enteropathogenic Yersinia)R9-6-3108Zika Virus Infection